Development and external validation of a predictive model for postoperative recurrence of Crohn's disease in the biologic era.

Date publication

mars 2026

Journal

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Auteurs

Membres identifiés du Cancéropôle Est :
Pr PEYRIN-BIROULET Laurent

Tous les auteurs :
Allez M, Bak MTJ, Brand S, Diebakate-Scordamaglia L, Capelle E, Seksik P, Nancey S, Gornet JM, Buisson A, Carbonnel F, Peyrin-Biroulet L, Louis E, Hébuterne X, Serrero M, Bourreille A, Treton X, Wils P, Fumery M, Blanc P, Uzzan M, Sokol H, Barnich N, Kirchgesner J, Colombel JF, Maggiori L, Bezault M, Silverberg MS, De Vries AC, Lambert J, Hammoudi N

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/41905522

Résumé

Ileocolonic resection remains common in Crohn's disease (CD) despite increasing biologic use.

Mots clés

Crohn’s disease, biologic therapies, endoscopic recurrence, ileocolonic surgery, prophylaxis

Référence

Clin Gastroenterol Hepatol. 2026 03 27;: